NVCT- Nuvectis Pharma, Inc.

Over the past 90 days, insiders at Nuvectis Pharma, Inc. (NVCT) have been net buyers, picking up 62,500 shares worth roughly $1.2M on balance.

Classified under Biotechnology (Health Care sector), NVCT's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.69M	$82.07M	-
10%	Mosseri Marlio Charles	3.19M	$70.90M	-
Other	Poradosu Enrique	1.81M	$40.19M	-
Other	Shemesh Shay	1.79M	$39.90M	-
VP	Carson Michael J.	200.1K	$4.45M	-

Buys and sells only

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 6, 2023	Bentsur Ron64	Chairman &CEO	Buy	320	$14.88	$4,761.60	-	-27.5%	-59.3%
Jul 5, 2023	Mosseri Marlio Charles46	10% Owner	Buy	1,176	$15.52	$18,251.52	-	-29.5%	-60.9%
Jun 26, 2023	Bentsur Ron64	Chairman &CEO	Buy	750	$16.50	$12,375.00	-	-16.6%	-56.8%
Jun 26, 2023	Mosseri Marlio Charles46	10% Owner	Buy	16,760	$16.46	$275,869.60	+0.7%	-16.6%	-56.8%
Jun 23, 2023	Mosseri Marlio Charles46	10% Owner	Buy	73,175	$17.43	$1,275,440.25	+3.0%	-19.3%	-58.4%
Jun 22, 2023	Mosseri Marlio Charles46	10% Owner	Buy	13,090	$17.72	$231,963.88	+0.3%	-23.0%	-60.2%
Jun 21, 2023	Bentsur Ron64	Chairman &CEO	Buy	500	$17.88	$8,940.00	-	-19.7%	-61.5%
Jun 16, 2023	Mosseri Marlio Charles46	10% Owner	Buy	12,700	$17.75	$225,425.00	+0.5%	-22.5%	-62.6%
Jun 15, 2023	Mosseri Marlio Charles46	10% Owner	Buy	32,124	$17.71	$568,848.04	+0.7%	-23.6%	-62.8%
Jun 8, 2023	Bentsur Ron64	Chairman &CEO	Buy	350	$17.45	$6,107.90	-	-19.4%	-63.8%